Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0022 | 1 |
mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |